T his issue of Psychiatric Annals, guest edited by Dr. Stephen H. Dinwiddie, focuses on prediction in psychiatry. If prediction is possible, then prevention is at least a possibility. Prediction is difficult when a behavior results from equifinality, which is when different mechanisms lead to the same outcome. Both suicide and violence have multiple mechanisms-difficult to predict, and therefore, difficult to prevent.
In the guest editorial, Dr. Dinwiddie points out that this issue is not to supply a "checklist" of how to assess risk, but for clinicians to think about how to assess risk. He has chosen two areas of greatest importance: suicide and interpersonal violence. Another aspect to consider is whether a risk factor is modifiable by treatment or not.
The first article, "From Ballpark to Courtroom: How Baseball Explains Risk Assessment," by Drs. Christopher P. Marett and Douglas Mossman uses the sport of baseball (our national pastime) to illustrate types of risk assessment and to explain how risk assessment tools apply statistical concepts.
In the next article, "A Review of Violence Risk Assessment for the General Clinician," Dr. Mark Chapman addresses situations in which the mental health professional does not have the clinical tools available when there is a need to evaluate violence risk.
In the third article, "Structured Approaches to Violence Risk Assessment: A Critical Review," Dr. Michael Brook tells us that structured professional judgment relies on specialized expertise, organized checklist applications, and multimethod approaches to violence risk assessment.
Next, in the article, "Thinking About (Completed) Suicide," Drs. Sam Libeu and Dinwiddie point out that the absence of short-term risk factors does not necessarily mean that a patient will not commit suicide.
In Prediction is difficult when a behavior results from equifinality, which is when different mechanisms lead to the same outcome.
editorial comorbid panic disorder, generalized anxiety disorder, and anxiety disorder (not otherwise specified). This study showed that patients that had certain comorbid anxiety disorders, such as panic disorder, generalized anxiety disorder, and anxiety disorder (not otherwise specified), but not obsessive-compulsive disorder and posttraumatic stress disorder had a significantly higher rate of suicide, and that patients who were prescribed higher doses of benzodiazepines had a significantly higher odds ratio of suicide. The interpretation was that more severe levels of anxiety lead to higher rates of suicide, but benzodiazepines did not look very effective at reducing suicide in this large study. 2 This supports the notion of high benzodiazepines being associated more significantly with suicide, and suggests that benzodiazepines are not an effective treatment for the severe anxiety often preceding suicide. Another article 3 shows that quetiapine reduced irritability and risk of suicide in three patients with agitated depression. The study suggests that the use of quetiapine can rapidly reduce psychomotor agitation and can rapidly reduce symptoms of anxiety and agitation. 4 A study 5 of bipolar disorder and comorbid anxiety has shown that suicidal risk is greater in patients with severe anxiety. The authors indicate that olanzapine (an atypical antipsychotic) and lamotrigine (an anticonvulsant) control anxiety symptoms in patients with bipolar disorder. 5 The Canadian Network for Mood and Anxiety Treatments has published guidelines discussing the role of managing severe anxiety symptoms as an important tool in the holistic management of suicide risk with certain atypical antipsychotics such as olanzapine. 6 
